Tuesday, 29 September 2026Updated 8m ago
← Top stories
▲ Bullish for Godavari Biorefineries

Godavari Biorefineries secures a Chinese patent for viral infection treatment compounds

1 source · first seen 18:08 29 Sept · updated 18:08 29 Sept

The brief

Written from 1 report · check the source before you trade
  • Chinese patent covers compounds that inhibit V-ATPase, a cellular mechanism some viruses use during infection

Tags on this story

Pick a tag to see all its stories
Godavari Biorefineries₹236.48 · 1 todayChina43 todayPharma and healthcare46 today

Linked by the tag Pharma and healthcare

123 stories this week
  1. 29 SeptExpanding innovative portfolio may drive gains for Sun Pharma stockBroker call · 1 source · Lerodalcibep licensing, US portfolio growth and tariff relief are cited as potential stock drivers
  2. 29 SeptSun Pharma Plans Rs 10,000 Crore Rupee Debt Sale To Refinance Organon Deal: ReportFunding and debt · 1 source · Sun Pharma plans a ₹10,000 crore bond sale to refinance its Organon deal
  3. 29 SeptSun Pharma plans $1 billion local debt sale for loan takeout, sources sayFunding and debt · 3 sources · Sun Pharma plans to raise about ₹10,000 crore through rupee-denominated bonds
  4. 29 SeptZydus hits 52-week high, can the optimism continue?Market move · 1 source · Zydus Lifesciences has gained 32% in 2026
  5. 29 SeptNifty Pharma defies market slump as select drugs get US tariff exemptionMarket move · 3 sources · Qualifying speciality medicines from India will be eligible for zero US duty
All Pharma and healthcare stories →

Read the reports

1 report · earliest 18:08
Business LineGodavari Biorefineries secures a Chinese patent for viral infection treatment compounds18:08